InspireMD, Inc.
NSPR
$2.56
-$0.10-3.76%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.68% | 4.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.68% | 4.08% | |||
| Cost of Revenue | 6.02% | -0.85% | |||
| Gross Profit | 13.29% | 25.08% | |||
| SG&A Expenses | 23.83% | -4.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.16% | 2.73% | |||
| Operating Income | -10.69% | -2.45% | |||
| Income Before Tax | -15.53% | 0.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.27% | 0.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.27% | 0.24% | |||
| EBIT | -10.69% | -2.45% | |||
| EBITDA | -10.72% | -2.42% | |||
| EPS Basic | -15.02% | 26.00% | |||
| Normalized Basic EPS | -4.81% | 26.05% | |||
| EPS Diluted | -15.02% | 26.00% | |||
| Normalized Diluted EPS | -4.81% | 26.05% | |||
| Average Basic Shares Outstanding | 1.08% | 34.82% | |||
| Average Diluted Shares Outstanding | 1.08% | 34.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
